Related content

The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy

By Lee P. H.   Lee G.   Park H. J.   Bang O. Y.   Joo I. S.   Huh K.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1435-1439

Springer Publishing Company

Access to resources Recommend Favorite

Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment

By Blandini F.   Cosentino M.   Mangiagalli A.   Marino F.   Samuele A.   Rasini E.   Fancellu R.   Tassorelli C.   Pacchetti C.   Martignoni E.   Riboldazzi G.   Calandrella D.   Lecchini S.   Frigo G.   Nappi G.  

Journal of Neural Transmission, Vol. 111, Iss. 8, 2004-08 ,pp. : 1017-1030

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial

By Tolosa Eduardo   Hernández Basilio   Linazasoro Gurutz   López-Lozano Juan   Mir Pablo   Marey José   Kulisevsky Jaime  

Journal of Neural Transmission, Vol. 121, Iss. 4, 2014-04 ,pp. : 357-366

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson’s disease

By Müller T.   Erdmann C.   Muhlack S.   Bremen D.   Przuntek H.   Goetze O.   Woitalla D.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1441-1448

Springer Publishing Company

Access to resources Recommend Favorite

Apathy in patients with Parkinson’s disease

By Shulman Lisa M.  

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 298-306

Informa Healthcare

Access to resources Recommend Favorite